DJ, K., JC, S., T, S., S, M., TL, K., SW, Y., . . . LA, G. (2026). Real-world outcomes of delandistrogene moxeparvovec gene therapy: Motor outcomes and emerging safety concerns. Molecular therapy : the journal of the American Society of Gene Therapy, 34(1), 123. https://doi.org/10.1016/j.ymthe.2025.10.007
Chicago Style (17th ed.) CitationDJ, Keselman, et al. "Real-world Outcomes of Delandistrogene Moxeparvovec Gene Therapy: Motor Outcomes and Emerging Safety Concerns." Molecular Therapy : The Journal of the American Society of Gene Therapy 34, no. 1 (2026): 123. https://doi.org/10.1016/j.ymthe.2025.10.007.
MLA (9th ed.) CitationDJ, Keselman, et al. "Real-world Outcomes of Delandistrogene Moxeparvovec Gene Therapy: Motor Outcomes and Emerging Safety Concerns." Molecular Therapy : The Journal of the American Society of Gene Therapy, vol. 34, no. 1, 2026, p. 123, https://doi.org/10.1016/j.ymthe.2025.10.007.